FDA Approves New Atrial Fibrillation Device

The FDA has approved Boston Scientifics new device for stroke patients with irregular heart rhythm known as atrial fibrillation, and will be made available to U.S. centers involved in Boston Scientific’s clinical studies and additional specialized centers,...

Valeant Pharmaceuticals Increases Offer for Salix

According to Reuters.com, “Valeant Pharmaceuticals has increased its takeover offer for Salix Pharmaceuticals to $10.96 billion in cash…bumping out Endo International Plc, the only other bidder for the maker of gastrointestinal drugs.”  Salix has...